Logo image of BKHT.DE

BROCKHAUS TECHNOLOGIES AG (BKHT.DE) Stock Fundamental Analysis

Europe - FRA:BKHT - DE000A2GSU42 - Common Stock

12 EUR
-0.4 (-3.23%)
Last: 10/17/2025, 7:00:00 PM
Fundamental Rating

3

BKHT gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 56 industry peers in the Electronic Equipment, Instruments & Components industry. BKHT has a bad profitability rating. Also its financial health evaluation is rather negative. BKHT has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year BKHT has reported negative net income.
BKHT had a positive operating cash flow in the past year.
In the past 5 years BKHT reported 4 times negative net income.
BKHT had a positive operating cash flow in 4 of the past 5 years.
BKHT.DE Yearly Net Income VS EBIT VS OCF VS FCFBKHT.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M

1.2 Ratios

BKHT has a Return On Assets of -9.27%. This is amonst the worse of the industry: BKHT underperforms 80.36% of its industry peers.
BKHT's Return On Equity of -27.74% is on the low side compared to the rest of the industry. BKHT is outperformed by 71.43% of its industry peers.
BKHT has a Return On Invested Capital of 3.34%. This is comparable to the rest of the industry: BKHT outperforms 50.00% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for BKHT is below the industry average of 7.06%.
Industry RankSector Rank
ROA -9.27%
ROE -27.74%
ROIC 3.34%
ROA(3y)-0.86%
ROA(5y)-1.47%
ROE(3y)-3.92%
ROE(5y)-4.38%
ROIC(3y)3.92%
ROIC(5y)N/A
BKHT.DE Yearly ROA, ROE, ROICBKHT.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20

1.3 Margins

The Operating Margin of BKHT (11.68%) is better than 85.71% of its industry peers.
BKHT has a Gross Margin of 66.46%. This is amongst the best in the industry. BKHT outperforms 87.50% of its industry peers.
In the last couple of years the Gross Margin of BKHT has declined.
Industry RankSector Rank
OM 11.68%
PM (TTM) N/A
GM 66.46%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.9%
GM growth 5Y-3.63%
BKHT.DE Yearly Profit, Operating, Gross MarginsBKHT.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100

2

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so BKHT is destroying value.
The number of shares outstanding for BKHT has been reduced compared to 1 year ago.
BKHT has more shares outstanding than it did 5 years ago.
BKHT has a worse debt/assets ratio than last year.
BKHT.DE Yearly Shares OutstandingBKHT.DE Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
BKHT.DE Yearly Total Debt VS Total AssetsBKHT.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

Based on the Altman-Z score of 0.74, we must say that BKHT is in the distress zone and has some risk of bankruptcy.
BKHT has a worse Altman-Z score (0.74) than 83.93% of its industry peers.
BKHT has a debt to FCF ratio of 6.83. This is a slightly negative value and a sign of low solvency as BKHT would need 6.83 years to pay back of all of its debts.
BKHT has a Debt to FCF ratio (6.83) which is comparable to the rest of the industry.
BKHT has a Debt/Equity ratio of 1.02. This is a high value indicating a heavy dependency on external financing.
The Debt to Equity ratio of BKHT (1.02) is worse than 78.57% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.02
Debt/FCF 6.83
Altman-Z 0.74
ROIC/WACC0.73
WACC4.59%
BKHT.DE Yearly LT Debt VS Equity VS FCFBKHT.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M 250M

2.3 Liquidity

BKHT has a Current Ratio of 1.27. This is a normal value and indicates that BKHT is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.27, BKHT is not doing good in the industry: 62.50% of the companies in the same industry are doing better.
BKHT has a Quick Ratio of 1.06. This is a normal value and indicates that BKHT is financially healthy and should not expect problems in meeting its short term obligations.
With a Quick ratio value of 1.06, BKHT perfoms like the industry average, outperforming 57.14% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.27
Quick Ratio 1.06
BKHT.DE Yearly Current Assets VS Current LiabilitesBKHT.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 50M 100M

4

3. Growth

3.1 Past

BKHT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -1042.52%.
BKHT shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 9.48%.
The Revenue has been growing by 65.29% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-1042.52%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-820.13%
Revenue 1Y (TTM)9.48%
Revenue growth 3Y73.62%
Revenue growth 5Y65.29%
Sales Q2Q%-34.05%

3.2 Future

Based on estimates for the next years, BKHT will show a very negative growth in Earnings Per Share. The EPS will decrease by -11.59% on average per year.
The Revenue is expected to grow by 7.48% on average over the next years.
EPS Next Y-53%
EPS Next 2Y0.21%
EPS Next 3Y-11.59%
EPS Next 5YN/A
Revenue Next Year-1.74%
Revenue Next 2Y7.92%
Revenue Next 3Y9.43%
Revenue Next 5Y7.48%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
BKHT.DE Yearly Revenue VS EstimatesBKHT.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 100M 200M 300M
BKHT.DE Yearly EPS VS EstimatesBKHT.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 0.5 1 1.5 2

4

4. Valuation

4.1 Price/Earnings Ratio

BKHT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
BKHT is valuated reasonably with a Price/Forward Earnings ratio of 10.74.
Based on the Price/Forward Earnings ratio, BKHT is valued a bit cheaper than 73.21% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.94, BKHT is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 10.74
BKHT.DE Price Earnings VS Forward Price EarningsBKHT.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, BKHT is valued cheaper than 92.86% of the companies in the same industry.
BKHT's Price/Free Cash Flow ratio is rather cheap when compared to the industry. BKHT is cheaper than 89.29% of the companies in the same industry.
Industry RankSector Rank
P/FCF 3.33
EV/EBITDA 3.48
BKHT.DE Per share dataBKHT.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10 15

4.3 Compensation for Growth

A cheap valuation may be justified as BKHT's earnings are expected to decrease with -11.59% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y0.21%
EPS Next 3Y-11.59%

0

5. Dividend

5.1 Amount

BKHT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

BROCKHAUS TECHNOLOGIES AG

FRA:BKHT (10/17/2025, 7:00:00 PM)

12

-0.4 (-3.23%)

Chartmill FA Rating
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)08-11 2025-08-11
Earnings (Next)11-14 2025-11-14
Inst Owners18.88%
Inst Owner ChangeN/A
Ins Owners36.95%
Ins Owner ChangeN/A
Market Cap125.40M
Analysts88
Price Target35.7 (197.5%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.21
Dividend Growth(5Y)N/A
DP-4.14%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-23.08%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-55.58%
EPS NY rev (3m)-67.26%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-14.75%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 10.74
P/S 0.61
P/FCF 3.33
P/OCF 3.06
P/B 0.63
P/tB N/A
EV/EBITDA 3.48
EPS(TTM)-5.32
EYN/A
EPS(NY)1.12
Fwd EY9.31%
FCF(TTM)3.61
FCFY30.05%
OCF(TTM)3.93
OCFY32.71%
SpS19.55
BVpS19.17
TBVpS-8.68
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -9.27%
ROE -27.74%
ROCE 4.76%
ROIC 3.34%
ROICexc 3.69%
ROICexgc 10.26%
OM 11.68%
PM (TTM) N/A
GM 66.46%
FCFM 18.45%
ROA(3y)-0.86%
ROA(5y)-1.47%
ROE(3y)-3.92%
ROE(5y)-4.38%
ROIC(3y)3.92%
ROIC(5y)N/A
ROICexc(3y)4.35%
ROICexc(5y)N/A
ROICexgc(3y)12.33%
ROICexgc(5y)N/A
ROCE(3y)5.57%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.9%
GM growth 5Y-3.63%
F-Score5
Asset Turnover0.34
Health
Industry RankSector Rank
Debt/Equity 1.02
Debt/FCF 6.83
Debt/EBITDA 2.15
Cap/Depr 4.65%
Cap/Sales 1.63%
Interest Coverage 4.77
Cash Conversion 42.99%
Profit Quality N/A
Current Ratio 1.27
Quick Ratio 1.06
Altman-Z 0.74
F-Score5
WACC4.59%
ROIC/WACC0.73
Cap/Depr(3y)10.66%
Cap/Depr(5y)11.96%
Cap/Sales(3y)1.63%
Cap/Sales(5y)2.21%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1042.52%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-820.13%
EPS Next Y-53%
EPS Next 2Y0.21%
EPS Next 3Y-11.59%
EPS Next 5YN/A
Revenue 1Y (TTM)9.48%
Revenue growth 3Y73.62%
Revenue growth 5Y65.29%
Sales Q2Q%-34.05%
Revenue Next Year-1.74%
Revenue Next 2Y7.92%
Revenue Next 3Y9.43%
Revenue Next 5Y7.48%
EBIT growth 1Y-24.17%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-4.48%
EBIT Next 3Y1.43%
EBIT Next 5YN/A
FCF growth 1Y21.28%
FCF growth 3YN/A
FCF growth 5Y139.23%
OCF growth 1Y17.88%
OCF growth 3YN/A
OCF growth 5Y95.78%